checkAd

     113  0 Kommentare Covalon Announces Participation in APIC Annual Conference & Exposition on June 26 – 28, 2023 in Orlando, Florida

    Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced that it is participating in the 2023 APIC Annual Conference and Exposition in Orlando, Florida from June 26 to 28, 2023. Healthcare providers looking to strengthen their infection prevention toolkit with patient-centered medical technology should visit Covalon at booth 612 to learn more about Covalon’s unique compassionate care solutions.

    This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230626454700/en/

    IV Clear dressing applied to an IV insertion site, and VALGuard applied to a line connection. Contamination of IV setups is a common source of catheter-related bloodstream infections and require special handling procedures and protection to minimize health risks to patients. (Photo: Business Wire)

    IV Clear dressing applied to an IV insertion site, and VALGuard applied to a line connection. Contamination of IV setups is a common source of catheter-related bloodstream infections and require special handling procedures and protection to minimize health risks to patients. (Photo: Business Wire)

    APIC, the Association for Professionals in Infection Control and Epidemiology, is the leading professional association for infection preventionists (IPs), with more than 15,000 members. The conference brings together more than 3,000 nurses, physicians, public health professionals, academia, epidemiologists, microbiologists, medical technologists, and industry to advance knowledge sharing, collaboration, and scientific innovation in the area of infection prevention and control.

    “Providing patients thorough protection against infections should not come at the compromise of providing gentle, compassionate care,” said Ron Hebert, Senior Vice President, Marketing, Covalon. “Healing shouldn’t hurt, which is why at Covalon we are laser focused on developing medical technology that gives patients their best defense against infection, without causing unnecessary pain, trauma, or tears.”

    Covalon representatives will be available to meet with participants on site. To make an appointment, please contact Ron Hebert, SVP Marketing, at rhebert@covalon.com.

    Covalon’s suite of infection prevention solutions include:

    • VALGuard - an FDA listed, transparent, environmental barrier designed to protect catheter hubs and line connections from external contaminants and gross contamination, including body fluids and other secretions. It incorporates a quick-release pull strip for fast access to infusion hubs and for easy removal.
    • IV Clear - the world’s only dual-antimicrobial vascular access dressing that offers complete transparency at and around the insertion site for easy daily assessment. It also utilizes soft silicone adhesive technology to minimize skin injuries and preserve skin barrier functions, and incorporates safe amounts of antimicrobials, without sacrificing efficacy, to protect against chemical irritation.

    Conference details

    Seite 1 von 3



    Business Wire (engl.)
    0 Follower
    Autor folgen

    Weitere Artikel des Autors


    Covalon Announces Participation in APIC Annual Conference & Exposition on June 26 – 28, 2023 in Orlando, Florida Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced that it is participating in the 2023 APIC Annual Conference and Exposition in Orlando, Florida from June 26 …